Chronic obstructive pulmonary disease (COPD)
341 results
1 - 100
Tai Chi for chronic obstructive pulmonary disease (COPD)- Influenza vaccine for chronic obstructive pulmonary disease (COPD)
- Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD)
- Cognitive behavioural approaches for managing dyspnoea in people with chronic obstructive pulmonary disease (COPD)
- Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
- Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD)
- Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD)
- Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)
- Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD)
- Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD)
- Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)
- Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta‐analysis
- Antibiotics for exacerbations of chronic obstructive pulmonary disease
- Pulmonary rehabilitation for chronic obstructive pulmonary disease
- Nutritional supplementation for stable chronic obstructive pulmonary disease: Cochrane systematic review
- Airway clearance techniques for chronic obstructive pulmonary disease
- Statins versus placebo for people with chronic obstructive pulmonary disease: Cochrane systematic review
- Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease: Cochrane systematic review
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Oral corticosteroids for stable chronic obstructive pulmonary disease
- Oral theophylline for chronic obstructive pulmonary disease
- Breathing exercises for chronic obstructive pulmonary disease: Cochrane systematic review
- Short‐term ambulatory oxygen for chronic obstructive pulmonary disease
- Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease
- The effect of adding inhaled corticosteroids to tiotropium and long-acting beta 2 -agonists for chronic obstructive pulmonary disease: Cochrane systematic review
- Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease: Cochrane systematic review
- Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
- Integrated disease management interventions for patients with chronic obstructive pulmonary disease
- Pressurised metered‐dose inhalers versus all other hand‐held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease
- Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease: Cochrane systematic review
- Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
- Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
- Home care by outreach nursing for chronic obstructive pulmonary disease
- Short‐acting beta2‐agonists for stable chronic obstructive pulmonary disease
- Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease
- Proton pump inhibitors for chronic obstructive pulmonary disease
- Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
- Anti‐IL‐5 therapies for chronic obstructive pulmonary disease
- Domiciliary oxygen for chronic obstructive pulmonary disease
- Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease
- Heliox for treatment of exacerbations of chronic obstructive pulmonary disease
- Vitamin D for the management of chronic obstructive pulmonary disease
- Oxygen therapy during exercise training in chronic obstructive pulmonary disease
- Tiotropium for stable chronic obstructive pulmonary disease
- Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
- Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease
- Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
- Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease
- Smoking cessation for people with chronic obstructive pulmonary disease
- Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
- Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease: Cochrane systematic review
- Chronic non‐invasive ventilation for chronic obstructive pulmonary disease
- Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease
- Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease: Cochrane systematic review
- Telehealthcare for chronic obstructive pulmonary disease
- Smoking cessation for chronic obstructive pulmonary disease
- Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease
- Tiotropium versus placebo for chronic obstructive pulmonary disease
- Long‐acting beta2‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta2‐agonist alone for chronic obstructive pulmonary disease
- Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease
- Self‐management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease
- Singing for adults with chronic obstructive pulmonary disease
- Inhaled corticosteroids with combination inhaled long‐acting beta2‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
- Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
- Self‐management interventions for people with chronic obstructive pulmonary disease
- Antibiotics for exacerbations of chronic obstructive pulmonary disease